|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer Statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001.PubMed/NCBI
|
|
3
|
Naruke T, Tsuchiya R, Kondo H and Asamura
H: Prognosis and survival after resection for bronchogenic
carcinoma based on the 1997 TNM-staging classification: the
Japanese experience. Ann Thorac Surg. 71:1759–1764. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH: Comparison of
four chemotherapy regimens for advanced non-small cell lung cancer.
N Engl J Med. 346:92–98. 2002. View Article : Google Scholar
|
|
5
|
Tanaka-Okamoto M, Hori K, Ishizaki H,
Hosoi A, Itoh Y, Wei M, Wanibuchi H, Mizoguchi A, Nakamura H and
Miyoshi J: Increased susceptibility to spontaneous lung cancer in
mice lacking LIM-domain only 7. Cancer Sci. 100:608–616. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harris BZ and Lim WA: Mechanism and role
of PDZ domains in signaling complex assembly. J Cell Sci.
114:3219–3231. 2001.PubMed/NCBI
|
|
7
|
Kadrmas JL and Beckerle MC: The LIM
domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell
Biol. 5:920–931. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holaska JM, Rais-Bahrami S and Wilson KL:
Lmo7 is an emerin-binding protein that regulates the transcription
of emerin and many other muscle-relevant genes. Hum Mol Genet.
15:3459–3472. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ooshio T, Irie K, Morimoto K, Fukuhara A,
Imai T and Takai Y: Involvement of LMO7 in the association of two
cell-cell adhesion molecules, nectin and E-cadherin, through afadin
and α-actinin in epithelial cells. J Biol Chem. 279:365–373.
2004.
|
|
10
|
Nakamura H, Mukai M, Komatsu K,
Tanaka-Okamoto M, Itoh Y, Ishizaki H, Tatsuta M, Inoue M and
Miyoshi J: Transforming growth factor-β1 induces LMO7 while
enhancing the invasiveness of rat ascites hepatoma cells. Cancer
Lett. 220:95–99. 2005.
|
|
11
|
Akedo A, Shinkai K, Mukai M, Mori Y,
Tateishi R, Tanaka K, Yamamoto R and Morishita T: Interaction of
rat ascites hepatoma cells with cultured mesothelial cell layers: a
model for tumor invasion. Cancer Res. 46:2416–2422. 1986.PubMed/NCBI
|
|
12
|
Mukai M, Shinkai K, Komatsu K and Akedo H:
Potentiation of invasive capacity of rat ascites hepatoma cells by
transforming growth factor-β. Jpn J Cancer Res. 80:107–110.
1989.
|
|
13
|
Kang S, Xu H, Duan X, Liu J-J, He Z, Yu F,
Zhou S, Meng X-Q, Cao M and Kennedy G: PCD1, a novel gene
containing PDZ and LIM domains, is overexpressed in several human
cancers. Cancer Res. 60:5296–5302. 2000.PubMed/NCBI
|
|
14
|
Furuya M, Tsuji N, Endoh T, Moriai R,
Kobayashi D, Yagihashi A and Watanabe N: A novel gene containing
PDZ and LIM domains, PCD1, is overexpressed in human colorectal
cancer. Anticancer Res. 22:4183–4186. 2002.PubMed/NCBI
|
|
15
|
Sasaki M, Tsuji N, Furuya M, Kondoh K,
Kamagata C, Kobayashi D, Yagihashi A and Watanabe N: PCD1, a novel
gene containing PDZ and LIM domains, is overexpressed in human
breast cancer and linked to lymph node metastasis. Anticancer Res.
23:2717–2721. 2003.PubMed/NCBI
|
|
16
|
Kainu T, Juo SH, Desper R, et al: Somatic
deletions in hereditary breast cancers implicate 13q21 as a
putative novel breast cancer susceptibility locus. Proc Natl Acad
Sci USA. 97:9603–9608. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rozenblum E, Vahteristo P, Sandberg T, et
al: A genomic map of a 6-Mb region at 13q21–q22 implicated in
cancer development: identification and characterization of
candidate genes. Human Genet. 110:111–121. 2002.PubMed/NCBI
|
|
18
|
Thompson D, Szabo CI, Mangion J, et al:
Evaluation of linkage of breast cancer to the putative BRCA3 locus
on chromosome 13q21 in 128 multiple case families from the breast
cancer linkage consortium. Proc Natl Acad Sci USA. 99:827–831.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Travis WD, Colby TV, Corrin B, Shimosato Y
and Brambilla E: Histological typing of lung and pleural tumors.
World Health Organization International Histological Classification
of Tumors. 3rd edition. Springer; Berlin: 1999
|
|
20
|
Sobin L and Wittekind CH: TNM
Classification of Malignant Tumours. 6th edition. Wiley-Liss; New
York: 2002
|
|
21
|
Kaplan EL and Meier P: Nonparametric
estimation for incomplete observations. J Am Stat Assoc.
53:457–481. 1958. View Article : Google Scholar
|
|
22
|
Peto R, Pike MC, Armitage P, Breslow NE,
Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG:
Design and analysis of randomized clinical trials requiring
prolonged observation of each patient. II. Analysis and examples.
Br J Cancer. 35:1–39. 1977. View Article : Google Scholar
|
